IRELAND SUSAN LESLIE

Director · AMTM, C

As of 2026-09-16, IRELAND SUSAN LESLIE has 10 Form 4 transactions on record across 2 companies — 1 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Reconstructed holdings

Direct: $527KIndirect: $2.7M$3.2Mas of 2026-09-16
  • Direct $527K
  • Indirect $2.7M
Cindirect20,471 sh$2.7M
Cdirect2,688 sh$357K
AMTMdirect8,509 sh$169K

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

AMTM · 5 trades
2026-02-06: Award / grant, 5,062 sh ($0)2025-04-08: Award / grant, 11,564 sh ($0)2025-03-05: Option exercise, 3,447 sh ($0)2025-03-05: Option exercise, 3,447 sh2025-03-05: Option exercise, 3,447 sh
C · 5 trades
2025-04-01: Award / grant, 158 sh ($11K)2025-04-01: Award / grant, 16 sh ($1K)2025-01-02: Award / grant, 136 sh ($10K)2025-01-02: Award / grant, 24 sh ($2K)2025-01-02: Award / grant, 2,118 sh ($0)

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
10 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-02-06AMTMAward / grant5,0628,509Form 4
2025-04-08AMTMAward / grant11,56411,564Form 4
2025-04-01CAward / grant15820,471Form 4
2025-04-01CAward / grant162,688Form 4
2025-03-05AMTMOption exercise3,4470Form 4
2025-03-05AMTMOption exercise3,4473,447Form 4
2025-03-05AMTMOption exercise3,4473,447Form 4
2025-01-02CAward / grant13620,314Form 4
2025-01-02CAward / grant2420,178Form 4
2025-01-02CAward / grant2,1182,672Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.